As of 12:26:51 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-171,757.0000
-207,822.0000
-163,751.0000
-154,093.0000
-86,825.0000
Investing Cash Flow
102,218.0000
-44,458.0000
-114,180.0000
-18,115.0000
-284,832.0000
Financing Cash Flow
108.0000
237,303.0000
261,043.0000
178,521.0000
360,439.0000
End Cash Position
43,947.0000
30,719.0000
45,696.0000
62,584.0000
56,271.0000
Income Tax Paid Supplemental Data
--
140.0000
12.0000
20.0000
18.0000
Capital Expenditure
-394.0000
-583.0000
-2,548.0000
-6,107.0000
-758.0000
Issuance of Capital Stock
349.0000
237,303.0000
261,043.0000
179,667.0000
342,015.0000
Free Cash Flow
-172,151.0000
-208,405.0000
-166,299.0000
-160,200.0000
-87,583.0000
12/31/2020 - 4/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYMR Kymera Therapeutics, Inc.
40.61
+3.74%
LXEO Lexeo Therapeutics, Inc.
6.15
+1.82%
VTYX Ventyx Biosciences, Inc.
2.3300
+2.19%
ANAB AnaptysBio, Inc.
14.56
-2.93%
MRSN Mersana Therapeutics, Inc.
1.6350
-6.03%
FDMT 4D Molecular Therapeutics, Inc.
6.26
+8.30%
ZBIO Zenas BioPharma, Inc.
10.02
+2.66%
ITOS iTeos Therapeutics, Inc.
7.22
-0.07%
SLRN Acelyrin, Inc.
3.2000
-0.62%
NGNE Neurogene Inc.
23.17
+4.98%